related topics
{company, market, business}
{disease, patient, cell}
{work, book, publish}
{group, member, jewish}
{service, military, aircraft}
{school, student, university}
{rate, high, increase}
{land, century, early}
{area, community, home}
{food, make, wine}

Pfizer Incorporated (NYSEPFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), the antibiotic Zithromax (azithromycin), Viagra (sildenafil) for erectile dysfunction, and the anti-inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside the USA and Canada, mainly in South America). Its headquarters are in Midtown Manhattan, New York City.[3]

Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.[4]

Pfizer pleaded guilty in 2009 to the largest health care fraud in U.S. history and received the largest criminal penalty ever levied for illegal marketing of four of its drugs. Called a repeat offender, this was Pfizer's fourth such settlement with the U.S. Department of Justice in the previous ten years.[5][6] On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.[7] The deal was completed on October 15, 2009.[8]


Full article ▸

related documents
Economy of Uganda
Economy of Papua New Guinea
Economy of Samoa
Economy of Latvia
Economy of Tunisia
Economy of Paraguay
Time Warner
Orange (brand)
Economy of Botswana
Economy of Laos
Economy of Madagascar
Derivative (finance)
Ponzi scheme
Canadian dollar
Economy of Bulgaria
Carlyle Group
Economy of Cambodia
Economy of Nicaragua
Lloyd's of London
British Aerospace
Bausch & Lomb
Economy of Saint Kitts and Nevis
Local Exchange Trading Systems
Tertiary sector of the economy
Economy of the Netherlands
Economy of Libya